Pharma Journalist -

CytovanceBiologics, Inc. signed a non-exclusive license with Horizon Discovery for the use of their HD-BIOP3 Suspension adapted GS null CHO K1 cells. The Horizon CHO GS -/- cell line is…
Read More...

Recipharm and Sanofi have completed the acquisition of Sanofi’s inhalation contract manufacturing business including a manufacturing facility located in Holmes Chapel, UK. The…
Read More...

Novartis announced that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates that are part…
Read More...

Aptar Pharma continues its commitment to meeting new market trends with the release of an industry first, PureHale, a new portable and ready-to-use drug delivery solution designed for…
Read More...

CytoSen Therapeutics and KBI Biopharma announced a strategic partnership to manufacture therapeutic Natural Killer (NK) cells using a proprietary and scalable, closed system…
Read More...

SMi Reports: With just 4 weeks to go until the 8th Annual Orphan Drugs & Rare Diseases Conference, places for the conference and accompanying workshop on 16th October are becoming…
Read More...

Dr. Reddy’s Laboratories announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma Inc., a wholly owned subsidiary…
Read More...

Dragonfly Therapeutics announced a strategic collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to discover, develop and commercialize…
Read More...

Vertex Pharmaceuticals (Europe) Limited announced it has entered into an innovative access contract with the Danish pharmaceutical and procurement organization, Amgros. Effective from…
Read More...

Exclusive Speaker Interview with Brent Cezairliyan for SMi’s Superbugs & Superdrugs USA SMi are delighted to have interviewed, speaker, Brent Cezairliyan, Senior Scientist,…
Read More...